JTE-761

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameJTE-761
Drug Alias NameJTE-761
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma antagonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsHypersensitivityAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJapan Tobacco (Hong Kong) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJapan Tobacco (Hong Kong) Ltd
Inactive CompaniesN/A
Active IndicationsHypersensitivityAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A